Cargando…

Evaluation of Response to Immune Checkpoint Inhibitors Using a Radiomics, Lesion-Level Approach

SIMPLE SUMMARY: Unique responses such as hyperprogressive disease (HPD) and a dissociated response (DR) have been reported after immune checkpoint inhibitor (ICI) treatment, and these patterns are difficult to evaluate with conventional methods. The aim of this study was to evaluate radiomics featur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Chorog, Park, Hyunjin, Lee, Ho Yun, Lee, Seunghak, Ahn, Joong Hyun, Lee, Se-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657103/ https://www.ncbi.nlm.nih.gov/pubmed/34885160 http://dx.doi.org/10.3390/cancers13236050

Ejemplares similares

Tumor Margin Contains Prognostic Information: Radiomic Margin Characteristics Analysis in Lung Adenocarcinoma Patients
por: Lee, Geewon, et al.
Publicado: (2021)

Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors
por: Park, Changhee, et al.
Publicado: (2023)

Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?
por: Lee, Jiyun, et al.
Publicado: (2020)

Nondiagnostic, radial‐probe endobronchial ultrasound‐guided biopsy for peripheral lung lesions: The added value of radiomics from ultrasound imaging for predicting malignancy
por: Choi, Jihwan, et al.
Publicado: (2022)

Computed Tomography Radiomics for Residual Positron Emission Tomography-Computed Tomography Uptake in Lymph Nodes after Treatment
por: Kim, Chu Hyun, et al.
Publicado: (2020)

Prediction of tumor doubling time of lung adenocarcinoma using radiomic margin characteristics
por: Yoon, Hyun Jung, et al.
Publicado: (2020)

Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles
por: Yoon, Hyun Jung, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery
por: Lee, Min Ho, et al.
Publicado: (2021)

Are radiomics features universally applicable to different organs?
por: Lee, Seung-Hak, et al.
Publicado: (2021)

Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
por: Lee, Seon-Mi, et al.
Publicado: (2023)

Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach
por: Lee, So Won, et al.
Publicado: (2018)

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors
por: Kim, Hye Ryeon, et al.
Publicado: (2022)

Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea
por: Kim, Hyera, et al.
Publicado: (2020)

Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions
por: Lee, Geewon, et al.
Publicado: (2020)

Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma
por: Lee, Ahlim, et al.
Publicado: (2022)

Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2021)

Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer
por: Bak, So Hyeon, et al.
Publicado: (2019)

Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer
por: Lee, Seung-Hak, et al.
Publicado: (2019)

Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment
por: Kim, Hyunsu, et al.
Publicado: (2023)

Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma
por: Park, Sehhoon, et al.
Publicado: (2022)

How to use immune checkpoint inhibitor in ovarian cancer?
por: Park, Junsik, et al.
Publicado: (2019)

Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Lee, Ji Hyun, et al.
Publicado: (2023)

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
por: Lee, Yun-Gyoo, et al.
Publicado: (2021)

Subsequent Systemic Therapy following Platinum and Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
por: Hong, Joohyun, et al.
Publicado: (2022)

Classification of the glioma grading using radiomics analysis
por: Cho, Hwan-ho, et al.
Publicado: (2018)

The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria
por: Castello, Angelo, et al.
Publicado: (2022)

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
por: Gabryś, H. S., et al.
Publicado: (2022)

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
por: Cousin, François, et al.
Publicado: (2023)

Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8(+) T Cells
por: Lee, Se‐Hoon, et al.
Publicado: (2023)

Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach
por: Bak, So Hyeon, et al.
Publicado: (2018)

Pleomorphic carcinoma of the lung: Prognostic models of semantic, radiomics and combined features from CT and PET/CT in 85 patients
por: Kim, Chohee, et al.
Publicado: (2021)

Pathology of immune-mediated tissue lesions following treatment with immune checkpoint inhibitors
por: Ibraheim, Hajir, et al.
Publicado: (2019)

Radiomics-guided deep neural networks stratify lung adenocarcinoma prognosis from CT scans
por: Cho, Hwan-ho, et al.
Publicado: (2021)

CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
por: Li, Jiazheng, et al.
Publicado: (2023)

Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
por: Hyun, Jae-Won, et al.
Publicado: (2022)

A network-driven approach for genome-wide association mapping
por: Lee, Seunghak, et al.
Publicado: (2016)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
por: Lee, Juwon, et al.
Publicado: (2021)

The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Yang, Jieun, et al.
Publicado: (2022)

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors
por: Kim, Hana, et al.
Publicado: (2021)

Clinical Insights Into Novel Immune Checkpoint Inhibitors
por: Lee, Jii Bum, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m39ej4saa6bj5q6kjuccg062fm